A Metabonomics Profiling Study on Phlegm Syndrome and Blood-Stasis Syndrome in Coronary Heart Disease Patients Using Liquid Chromatography/Quadrupole Time-of-Flight Mass Spectrometry

<table>Disturbed metabolic pathways. Green font denoted biomarkers downregulations and red font denoted biomarkers upregulations (CHD/healthy people); yellow area denoted metabolites higher level and blue area denoted lower level (phlegm/blood stasis in CHD).</table>

Evidence-Based Complementary and Alternative Medicine

fig4

Figure 4

Figure 4: A Metabonomics Profiling Study on Phlegm Syndrome and Blood-Stasis Syndrome in Coronary Heart Disease Patients Using Liquid Chromatography/Quadrupole Time-of-Flight Mass Spectrometry 

Figure 4 | A Metabonomics Profiling Study on Phlegm Syndrome and Blood-Stasis Syndrome in Coronary Heart Disease Patients Using Liquid Chromatography/Quadrupole Time-of-Flight Mass Spectrometry 